New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 13, 2013
08:47 EDTMVCMVC Capital announces sale of Summit Research Labs
MVC Capital announced the signing of a definitive agreement to sell one of its portfolio companies, Summit Research Labs, a specialty chemical company that manufactures and markets antiperspirant actives globally, to an affiliate of One Rock Capital Partners, subject to regulatory approvals and the satisfaction of other customary closing conditions, including an escrow. Assuming full realization of the closing conditions and escrow and the sale of SCSD, MVC Capital would receive gross proceeds from its equity investment of approximately $63M, that results in an estimated gross IRR of 31% since August 2006. The gross IRR includes all fees and distributions received from its equity position in Summit over the life of the investment. The transaction is expected to close prior to March 31, 2013. The company is expected to record an approximate gain of $47M from the sale of the portfolio company.
News For MVC From The Last 14 Days
Check below for free stories on MVC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 9, 2014
17:32 EDTMVCMVC Capital reports Q3 net asset value per share $15.86 vs. $17.36 last year
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use